Rahima-Maoz C, Grossman E, Nussinovitch N, Katz A, Rosenthal T
A.J. Chorley Institute for Hypertension, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Cardiology. 1997;88 Suppl 3:43-6. doi: 10.1159/000177506.
The relative efficacy of two formulations of nifedipine, slow release (SR) and gastrointestinal therapeutic system (GITS), to lower blood pressure in hypertensive patients was evaluated in a prospective study. Nifedipine GITS 30 mg/day replaced nifedipine SR, 20 mg b.i.d. in 38 patients, 23 monitored by routine blood pressure measurements and 15 by ambulatory monitoring. Nifedipine GITS achieved a marked reduction in blood pressure with a smaller dose than nifedipine SR: 30 versus 40 mg/day, respectively. It is concluded that patients with hypertension controlled on a twice-daily dose of nifedipine prolonged action can be converted to a lower once-daily dose of nifedipine GITS without experiencing any increase in blood pressure. Tolerability and compliance improved when switching to the GITS formulation.
在一项前瞻性研究中,评估了硝苯地平的两种剂型(缓释型和胃肠道治疗系统型)在高血压患者中降低血压的相对疗效。38例患者中,硝苯地平胃肠道治疗系统型(GITS)每日30mg取代了硝苯地平缓释型(SR)每日20mg bid,其中23例通过常规血压测量进行监测,15例通过动态监测进行监测。硝苯地平GITS以比硝苯地平SR更小的剂量实现了血压的显著降低:分别为30mg/天和40mg/天。得出的结论是,接受每日两次剂量的长效硝苯地平治疗且血压得到控制的高血压患者,可以转换为每日一次较低剂量的硝苯地平GITS,而不会出现血压升高。改用GITS剂型时,耐受性和依从性有所改善。